GUFICBIO — Gufic Biosciences Share News
0.000.00%
Last trade - 00:00- IN₹39.29bn
- IN₹42.58bn
- IN₹9.44bn
Brief: Gufic Biosciences June-Quarter Consol Total Profit 223.1 Million Rupees
Brief: Gufic Biosciences Receives Tax Demand Notice For 43.3 Million Rupees
Brief: Gufic Biosciences Receives Tax Demand Notice For 43.3 Million Rupees
Brief: Gufic Biosciences posts Sept-Quarter Consol Revenue From Operations 2.37 Billion Rupees
Brief: Gufic Biosciences Invests AED 200,000 In Unit Veira Life
India's Gufic Biosciences falls on Q2 profit drop
Brief: Gufic Biosciences Sept-Quarter Consol Total Profit 217.7 Mln Rupees
Brief: Gufic Biosciences June-Quarter Net Profit From Cont Ops 208.6 Mln Rupees
Brief: Gufic Biosciences Says Granted Patent For Invention
Brief: Gufic Biosciences Dec-Qtr Total Profit Rises
Brief: Gufic Biosciences Says Co Granted Patent Of Addition For Freeze Dried Parenteral Composition Of Omadacycline Tosylate
Brief: India's Gufic Biosciences Sept-Quarter Net Profit From Continuing Operations Rises
Brief: Gufic Biosciences Approves Incorporation Of Unit In Dubai, UAE
India's Gufic Biosciences rises on patent grant
Brief: Gufic Biosciences Granted Patent For "Freeze Dried Parenteral Composition Of Omadacycline Tosylate, Process For Preparation Thereof"
India's Gufic Biosciences up on Australia, Brazil nod for parecoxib injection
Brief: Gufic Biosciences Receives TGA Australia And ANVISA Brazil Approval For Parecoxib 40Mg Injection
India's Gufic Biosciences jumps on Motilal investment
Brief: Gufic Biosciences To Issue Shares To Motilal Oswal Financial Services